The vaccine candidate has yet to finish clinical trails and no efficacy data is available, but Taiwan's health ministry said studies so far have shown that antibodies created by the shot have been "no worse than"those created by AstraZeneca's )
過去 31 日間
0 回のレビューがあります
この情報に 0 件のリプライがあります
No response has been written yet. It is recommended to maintain a healthy skepticism towards it.